Heart Failure
Conditions
Keywords
Heart Failure, NYHA class, Sacubitril/Valsartan, Chronic kidney disease
Brief summary
This study looks at people with heart failure who are admitted to the hospital. The goal of the study is to understand whether taking a heart failure medicine called angiotensin receptor-neprilysin inhibitor (ARNI) before hospital admission affects short-term health outcomes. The study will compare two groups of participants: those who were already taking ARNI before coming to the hospital and those who were not. Information will be collected from medical records during the hospital stay, including heart-related events, kidney-related events, and how long participants stay in the hospital. Some participants will also be followed for a short period after discharge. This study may help improve understanding of outcomes associated with ARNI use in people with heart failure in routine clinical care.
Interventions
OTHERNo prehospital ARNI use
Participants who were not using ARNI therapy before hospital admission
OTHERPrehospital ARNI use
Participants who were using ARNI therapy before hospital admission
Sponsors
Future University in Egypt
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* \>= 18 years, male or female EF \<40%
Exclusion criteria
* EF\>40% Pregnancy or breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In-hospital cardiac and renal events | 3 months |
Secondary
| Measure | Time frame |
|---|---|
| NYHA classification | 3 months |
Countries
Egypt
Outcome results
None listed